Participant Basic Agreement (PBA) Opportunity - Threat Agnostic Host-Directed Therapeutics

es interested parties to participate in the HEALER portfolio, a next-generation host directed medical countermeasure initiative. HEALER seeks to develop a diverse portfolio of threat agnostic, host-directed therapeutics that enhance the body�s ability to withstand, mitigate, and recover from the com

plex physiological impacts of CBRN threats. Because the underlying pathophysiology of injury following CBRN exposure and civilian critical care challenges are often governed by convergent host response mechanisms, this program creates a via